Oxidative Stress Activated by Sorafenib Alters the Temozolomide Sensitivity of Human Glioma Cells Through Autophagy and JAK2/STAT3-AIF Axis

The development of temozolomide (TMZ) resistance in glioma leads to poor patient prognosis. Sorafenib, a novel diaryl urea compound and multikinase inhibitor, has the ability to effectively cross the blood-brain barrier. However, the effect of sorafenib on glioma cells and the molecular mechanism un...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Jianwei, Wang, Zhengfeng, Wang, Weiwei, Liu, Xiaoge, Wan, Junhu, Yuan, Yongjie, Li, Xueyuan, Ma, Liwei, Liu, Xianzhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8282178/
https://www.ncbi.nlm.nih.gov/pubmed/34277607
http://dx.doi.org/10.3389/fcell.2021.660005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8282178/
https://www.ncbi.nlm.nih.gov/pubmed/34277607
http://dx.doi.org/10.3389/fcell.2021.660005

Ejemplares similares